Skip to content

In the BioHarmony Drug Report Database

Pancrelipase

Cotazym, Creon, Pancreaze, Pertzye, Viokace, Zenpep (pancrelipase) is an enzyme pharmaceutical. Pancrelipase was first approved as Cotazym on 1996-12-09. It is used to treat exocrine pancreatic insufficiency in the USA.
Trade Name Cotazym, Creon, Pancreaze, Pertzye, Viokace, Zenpep
Common Name Pancrelipase
Indication exocrine pancreatic insufficiency
Drug Class Enzymes
Pancrelipase
Get full access now